Revance Therapeutics Inc (NAS:RVNC)
$ 3.03 0.12 (4.12%) Market Cap: 316.48 Mil Enterprise Value: 502.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 59/100

Revance Therapeutics Inc (RVNC) Transcripts

  • 1